K2 Medical Research
Sean Stanton is a seasoned professional in clinical research and healthcare management with extensive experience spanning over three decades. As the Founder of K2 Medical Research, Stanton focuses on making clinical trials accessible to minority and underserved populations. Currently involved in strategic sourcing and business growth at C2N Diagnostics, Stanton also holds multiple key memberships, including the Young Presidents Organization Pacific Regional Board and the DAVOS Alzheimer’s Collaborative. With a strong leadership background, Stanton served as President and CEO of LifeCore Solutions, COO of Bioclinica, and Owner of Compass Research, a multi-therapeutic clinical trial center. Prior roles include Chief Operating Officer at CNS Healthcare, Inc., and Clinical Research Coordinator at the University of Cincinnati's Department of Psychiatry. Currently, Stanton is a member of the Board of Trustees at Western University of Health Sciences.
K2 Medical Research
Welcome to K2 Medical Research, a privately-owned clinical research facility in the greater Orlando area. We specialize in conducting multiphasic clinical trials that promote the development of innovative and effective medical treatments while maintaining the safety and privacy of our participants. Here at K2, we are committed to fighting the diseases that plague our loved ones and ourselves. By harnessing the power of advanced clinical research and connecting our patients with the treatments of tomorrow, we can improve the health of our local communities, and by extent, the population of our world. Areas of Research: •Alzheimer’s Disease •Liver Disease •Pain Psychiatric Disease •Cardiology •Diseases of the Nervous System •Diseases of the Endocrine •Rheumatology and Autoimmune Disorders •Diseases of the Gastrointestinal System •Diagnostics •Biomarkers •Food and Nutrition •COVID-19